肌肉心脏病发作和女性心力衰竭的特点
Milica Dekleva1, Ana Djordjevic2, Stefan Zivkovic3
1Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Journal of clinical medicine
|December 17, 2024
概括
尽管阻塞性冠状动脉疾病 (CAD) 较少,但女性在心肌梗塞 (MI) 后的结果更糟. 了解心脏重塑和输液中的基于性别的差异对于改善两性心脏病治疗和结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 医学中的性别和性别.
- 心血管研究研究心血管研究
背景情况:
- 在心脏形态学,病理生理学,冠状动脉疾病 (CAD) 和心肌梗塞 (MI) 临床过程中存在显著的基于性别的差异.
- 之前的研究强调了男性和女性如何发展和经历心脏病发作的差异,包括左心室 (LV) 重塑和心力衰竭 (HF).
研究的目的:
- 审查性别对心脏病发作和临床过程的影响.
- 调查LV重塑和HF后MI的性别特异性机制和特征.
- 探索"性别悖论",即女性在心脏病发作后死亡率较高,尽管阻塞性CAD患病率较低.
主要方法:
- 临床研究,随机试验和患者登记册的系统审查.
- 对LV重塑模式的性别相关差异的分析 (例如,男性的LV扩张与女性的同心重塑/高).
- 检查导致女性心肌输液受损的因素,包括微血管功能障碍和无反流现象.
主要成果:
- 妇女表现出较高的微血管功能障碍,冠状动脉流量储备受损和不回流现象的发病率,导致MI后心肌输液受损的频率更高.
- 与男性相比,女性的复发率,HF住院率和死亡率都增加了,不论年龄或并发症.
- "性别悖论"是显而易见的:尽管阻塞性CAD和减少射出分数 (HFrEF) 的HF的发病率较低,但女性面临更高的后心脏病死亡率.
结论:
- 性别特定的因素,如冠状动脉网络特征,微血管功能障碍,内皮炎症和延迟的再输,有助于女性后MI的结果更差.
- LV 重塑的差异 (男性的扩张与女性的同心变化) 影响临床过程.
- 更深入地了解基于性别的机制对于优化男性和女性的MI和HF疗法至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100
Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Mitral Regurgitation I: Introduction
1
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K


